The following information was accurate at the time of posting, but may be superceded by subsequent disclosure.
Dec 09, 2002Dec 03, 2002
INEX achieves positive Phase II/III clinical trial results
Dec 02, 2002
Onco TCS Pivotal Phase II/III Clinical Trial Data Release Call Notification
Nov 07, 2002
INEX Abstract for First-Line Lymphoma Accepted at ASH
Oct 31, 2002
INEX Releases Third Quarter Results
Oct 23, 2002
INEX Conference Call Notification for Q3 2002
Aug 15, 2002
INEX expands Onco TCS Clinical Program
Aug 07, 2002
INEX's Spinoff Protiva Closes Second Tranche of Financing
Aug 01, 2002
INEX Releases Second Quarter Results
Jul 31, 2002
INEX Receives Milestone Payments from GSK
Jul 25, 2002
INEX Second Quarter 2002 Conference Call Notification
Jun 10, 2002
INEX's Partner Elan Announces Plan to Evaluate Business Ventures
May 21, 2002
INEX Presents Interim First-line Lymphoma Data at ASCO
May 02, 2002
INEX Releases First Quarter Results
May 01, 2002
INEX Releases Interim Small Cell Lung Cancer Data
Apr 30, 2002
INEX Webcast Notification 2002 AGM
Apr 25, 2002
INEX First Quarter 2002 Conference Call Notification
Apr 09, 2002
INEX Reports to AACR on Targeted Chemotherapy Platform
Apr 08, 2002
INEX reports on OligoVax at AACR
Mar 14, 2002
INEX 2001 Operating Results & 2002 Milestones
Mar 07, 2002
INEX and Elan Reach Enrollment Target of 100
Mar 06, 2002
INEX 2001 year end conference call notification
Feb 12, 2002
New Onco TCS Phase II trial for Hodgkin's disease
